Description: Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Hydroxyurea Capsule USP from Vapi, Gujarat India. Common side effects of Hydroxyurea Nausea, Vomiting, Diarrhea, Fatigue, Constipation, Stomatitis (Inflammation of the mouth), Decreased appetite, Cholestasis, Hepatitis (viral infection of liver), Hair loss, Bone marrow depression, Low blood platelets, Skin rash, Mucositis Taj Pharma India is well known Manufacturer, Exporter and Supplier of Hydroxyurea Capsule USP 500mg from Vapi, Gujarat India. Follow your doctor’s instructions carefully. Do not change the dose or stop taking Hydroxyurea without your doctor’s advice, even if you feel better. Taj Pharma is a trusted name in the pharmaceutical industry, recognized as a top Hydroxyurea Capsule USP 500mg manufacturer and supplier in India. Based in Vapi, Gujarat, Taj Pharma specializes in producing high-quality, GMP-certified oncology and hematology medicines. Hydroxyurea Capsule USP 500mg is widely prescribed for chronic myeloid leukemia (CML), head and neck cancers, and sickle cell disease, owing to its ability to inhibit DNA synthesis and increase fetal hemoglobin levels in red blood cells. As a leading exporter to Africa, the Middle East, Latin America, and PAN India, Taj Pharma ensures strict adherence to international quality standards. Each batch of Hydroxyurea is manufactured under controlled conditions and supported with regulatory documents including COA, stability data, and CTD dossiers. Healthcare providers and pharma distributors trust Taj Pharma for its reliable supply chain, competitive pricing, and ethical business practices. Taj Pharma also offers PCD Pharma Franchise opportunities for Hydroxyurea Capsule USP 500mg, providing partners with marketing support and monopoly rights. Whether for domestic or international markets, Taj Pharma guarantees consistent quality and fast delivery. Taj Pharma India is well established Manufacturer, Exporter and Supplier of Hydroxyurea Capsule USP from Vapi, Gujarat India. In cancer, Hydroxyurea Capsule inhibits the enzyme ribonucleotide reductase, which plays a critical role in the synthesis of DNA by converting ribonucleotides into deoxyribonucleotides. This inhibition disrupts DNA synthesis, particularly in rapidly dividing cancer cells, resulting in cell cycle arrest and reduced tumor proliferation. In sickle cell disease, hydroxyurea increases the production of fetal hemoglobin (HbF) in red blood cells. Higher levels of HbF reduce the formation of sickled cells, improve red blood cell flexibility, enhance blood flow, and decrease the frequency of painful vaso-occlusive episodes and related complications.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 318 KB
